Security key
22053A107
Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX)
CUSIP: 22053A107
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 6,247,425
- Total 13F value
- $4,679,876
- Share change
- -1,024,586
- Put/Call ratio
- 2.4%
- SEC-reported price per share
- $0.75
- Number of holders
- 41
- Value change
- -$811,761
- Number of buys
- 12
- Number of sells
- 16
- Shares outstanding
- 60,216,782
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
41
Top holders
10
QNCX full security history
Ownership snapshot
Full 13F holder table
IRulya Therapeutics Inc. SEC filings
IRulya Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TANG CAPITAL MANAGEMENT LLC
Disclosed value leader
TANG CAPITAL MANAGEMENT LLC
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F
3/4/5
Highest disclosed value: $3,124,511
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
TANG CAPITAL MANAGEMENT LLC has the largest disclosed position value at $3.12M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TANG CAPITAL MANAGEMENT LLC's linked filing trail.
Disclosed position value
Top 5
TANG CAPITAL MANAGEMENT LLC
$3.12M
VANGUARD GROUP INC
$1.2M
EPIQ Capital Group, LLC
$896.5K
RENAISSANCE TECHNOLOGIES LLC
$551K
Philip S. Low
$488.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$3,124,511
2,947,652 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$1,199,422
1,131,530 shares
|
— | 31 Mar 2024 |
| EPIQ Capital Group, LLC |
13F
Company
|
—
denominator unverified
|
$896,519
845,773 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$551,000
520,100 shares
|
— | 31 Mar 2024 |
| Philip S. Low |
3/4/5
Director
|
—
mixed-class rows
|
$488,126
541,341 shares
mixed-class rows
|
— | 19 May 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$352,010
332,086 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
41
Shares
6,247,425
Rows available
41
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
44
Q2 2024 holders
41
Holder diff
-3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|